ClinicalTrials.Veeva

Menu

Treat Arterial Hypertension and Diabetes in Rural Africa (TAHADIRA)

C

Cooperation Afrique

Status

Completed

Conditions

Diabetes
Arterial Hypertension

Treatments

Other: Tracing and recall at home by a community worker
Other: Treatment contract
Other: Incentive

Study type

Interventional

Funder types

Other

Identifiers

NCT00744458
TAHADIRA

Details and patient eligibility

About

The purpose of this study is to determine the efficacy of three different interventions to improve treatment adherence among patients with arterial hypertension or diabetes in rural Cameroon.

Full description

Non communicable chronic diseases such as arterial hypertension (AH) and diabetes (DM) are a great burden for public health in Cameroon. However, outside the main cities access to appropriate diagnosis and treatment of these health-conditions is still very poor.

The Swiss NGO "Fondation Coopération Afrique" started in 2007 a program to integrate chronic disease management with focus on AH and DM into the primary health care system of peripheral non-physician health facilities in a rural area of Central Cameroon. A first evaluation after one year revealed very low treatment adherence among the newly diagnosed patients as the main challenge.

In order to improve patient's adherence we expose them randomly to one of three interventions:

The first intervention consists in a written agreement on long-lasting therapy (treatment contract). Patients get information about the importance of a regular long term treatment and personal engagement to follow treatment and clinical controls regularly.

The second intervention introduces in addition to the treatment contract a reminder system. In case of follow-up failure a community worker traces the patient to recall the visit at the health centre.

The third intervention consists of the treatment contract combined with a financial incentive in form of one month free treatment after four months of regular follow-up.

We allocated randomly one of the three interventions to each health center.

Enrollment

223 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with newly diagnosed arterial hypertension or non insulin dependent diabetes type 2 which require treatment and can be treated in the health centre
  • Informed consent by the patient

Exclusion criteria

  • Patient already under treatment
  • Patients who need to be referred to a hospital
  • No informed consent by the patient

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

223 participants in 3 patient groups

1
Active Comparator group
Treatment:
Other: Treatment contract
2
Active Comparator group
Treatment:
Other: Tracing and recall at home by a community worker
Other: Treatment contract
3
Active Comparator group
Treatment:
Other: Treatment contract
Other: Incentive

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems